share_log

HOOKIPA Pharma | 4: Statement of changes in beneficial ownership of securities-Director Kaufman David Ross

HOOKIPA Pharma | 4: Statement of changes in beneficial ownership of securities-Director Kaufman David Ross

HOOKIPA Pharma | 4:持股變動聲明-董事 Kaufman David Ross
美股SEC公告 ·  06/18 16:20

Moomoo AI 已提取核心訊息

David Ross Kaufman, a reporting person for HOOKIPA Pharma Inc. [HOOK], engaged in a transaction involving the company's stock on June 17, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. The address provided for Kaufman is associated with HOOKIPA Pharma's corporate offices in New York.
David Ross Kaufman, a reporting person for HOOKIPA Pharma Inc. [HOOK], engaged in a transaction involving the company's stock on June 17, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. The address provided for Kaufman is associated with HOOKIPA Pharma's corporate offices in New York.
HOOKIPA PHARMA的報告人David Ross Kaufman於2024年6月17日涉及公司股票的交易。具體交易的細節包括行動類型、狀態幣、涉及的股票數、股份的性質、交易價格和交易後的參股金融在公告中未披露。Kaufman提供的地址與HOOKIPA PHARMA在紐約的企業辦公室相關。
HOOKIPA PHARMA的報告人David Ross Kaufman於2024年6月17日涉及公司股票的交易。具體交易的細節包括行動類型、狀態幣、涉及的股票數、股份的性質、交易價格和交易後的參股金融在公告中未披露。Kaufman提供的地址與HOOKIPA PHARMA在紐約的企業辦公室相關。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息